Discovery of new heart failure trigger could change the way cardiovascular drugs are made
In their quest to treat cardiovascular disease, researchers and pharmaceutical companies have long been interested in developing new medicines that activate a heart protein called APJ. But researchers at Sanford-Burnham Medical ...
Jul 18, 2012
0
0